AHR vs WELL

Key Takeaways

• AHR and WELL are both healthcare real estate investment trusts (REITs) riding powerful secular tailwinds from aging demographics, but they operate at vastly different scales and strategic stages.
• WELL is an S&P 500 constituent with a market capitalization well above $100 billion and completed nearly $11 billion in net investment activity in 2025, while AHR commands a market cap of approximately $11 billion and deployed over $950 million in acquisitions during the same period.
• Both companies delivered exceptional same-store net operating income (SSNOI) growth in their senior housing portfolios during 2025, with AHR's SHOP (senior housing operating properties) segment posting 25.2% growth and WELL's SHO (seniors housing operating) portfolio generating its 13th consecutive quarter above 20%.
• WELL has been executing a transformative strategic pivot — selling a $7.2 billion outpatient medical portfolio while acquiring massive UK senior housing platforms — while AHR continues scaling its diversified model across integrated senior health campuses, outpatient medical, and triple-net leased properties.
• From a risk perspective, WELL benefits from A-grade credit ratings (S&P "A-" and Moody's "A3") and enormous liquidity, whereas AHR carries a smaller but improving balance sheet with net debt-to-EBITDA (earnings before interest, taxes, depreciation, and amortization) of 3.4x.
• Both names have delivered strong shareholder returns over the past year, but AHR has posted a higher percentage gain from its lower base, reflecting its earlier-stage growth trajectory relative to WELL's more mature compounding profile.

Introduction

Healthcare REITs have emerged as one of the most compelling real estate subsectors in recent years, powered by an accelerating demographic shift: the 80-plus population is expanding rapidly across the United States, Canada, and the United Kingdom. This structural tailwind creates a fertile backdrop for companies that own and operate senior housing, skilled nursing, and healthcare-related properties. American Healthcare REIT (AHR) and Welltower Inc. (WELL) represent two distinct expressions of this opportunity — one a relatively recent public-market entrant scaling aggressively, the other a well-established S&P 500 giant undergoing a bold strategic transformation. This comparison explores how these two healthcare real estate owners stack up across business models, recent performance, growth drivers, and risk profiles, offering a balanced perspective for investors evaluating exposure to the senior housing and healthcare property space.

AHR Overview and Recent Performance

American Healthcare REIT (AHR), headquartered in Irvine, California, is a self-managed healthcare REIT that owns and operates a diversified portfolio of clinical healthcare real estate across the United States, the United Kingdom, and the Isle of Man. The company went public in February 2024 and has since expanded its footprint across four reportable segments: Integrated Senior Health Campuses (ISHC), Senior Housing Operating Properties (SHOP), Outpatient Medical, and Triple-Net Leased Properties. The ISHC segment, operated primarily through its Trilogy platform, and the SHOP segment have been the standout performers.

In recent months, AHR has sustained remarkable momentum. For full-year 2025, the company reported total portfolio SSNOI growth of 14.2%, led by SHOP SSNOI growth of 25.2% and ISHC SSNOI growth of 18.4%. Normalized Funds from Operations (NFFO) — a key profitability metric for REITs that adjusts for non-cash items — reached $1.72 per diluted share, representing approximately 22% growth over the prior year. The company deployed over $950 million in acquisitions during 2025, primarily within its ISHC and SHOP segments. Looking ahead, management has guided for 2026 NFFO of $1.99 to $2.05 per share and total portfolio SSNOI growth of 7% to 11%. The stock has appreciated significantly over the trailing twelve months, reflecting robust operational execution and sustained demand for long-term care properties. Analysts have noted occupancy levels crossing above 90% in the SHOP segment, giving the company meaningful pricing power heading into the next phase of the cycle.

WELL Overview and Recent Performance

Welltower Inc. (WELL), based in Toledo, Ohio, is an S&P 500 company and one of the world's largest healthcare infrastructure REITs. The firm positions itself at the center of what it calls the "silver economy," focusing on rental housing for aging seniors across the United States, United Kingdom, and Canada. With a portfolio exceeding 2,000 seniors and wellness housing communities, WELL has increasingly defined itself as an operating company in a real estate wrapper, driven by its proprietary Welltower Business System — an end-to-end operating platform — and a data-science-powered approach to capital allocation.

The company delivered what management described as a "transformational" year in 2025. Revenue grew 36%, EBITDA (earnings before interest, taxes, depreciation, and amortization) rose 32%, and FFO (funds from operations) per share increased 22%, all while the balance sheet was deleveraged. The SHO portfolio posted its 13th consecutive quarter of SSNOI growth exceeding 20% in the fourth quarter of 2025, underpinned by 400 basis points of year-over-year occupancy gains and meaningful margin expansion. In a defining strategic move, WELL completed nearly $11 billion in net investment activity during 2025, including transformative UK acquisitions of the Barchester and HC-One senior housing platforms, while simultaneously divesting a $7.2 billion outpatient medical portfolio. The company ended 2025 with approximately $5.2 billion in cash and net debt-to-EBITDA of roughly 3.0x. Its 2026 normalized FFO guidance of $6.09 to $6.25 per share signals continued confidence in the growth trajectory. Notably, both S&P and Moody's upgraded WELL's credit ratings to A-category levels in 2025, reflecting the strength of its balance sheet and earnings power.

Trending AI Robots

In a market environment where sector rotation and macro uncertainty can shift sentiment rapidly, traders and investors are increasingly turning to artificial intelligence for data-driven decision-making. Tickeron's Trending AI Robots page offers a curated selection of the platform's highest-performing AI trading bots, chosen from hundreds of available bots that collectively trade thousands of different tickers. Only those bots that demonstrate strong alignment with current market conditions and consistent statistical performance earn a place in this featured section. These AI-powered systems employ a wide range of trading styles — from short-term swing trading to longer-duration trend-following strategies — and cover diverse sets of tickers, timeframes, and risk profiles. Many of the featured bots showcase annualized returns ranging from the high teens to well over 40%, depending on strategy and market regime, though past performance does not guarantee future results. For those seeking a systematic, emotion-free approach to navigating stocks like AHR and WELL, exploring Tickeron's Trending AI Robots may offer a valuable complement to traditional research.

Head-to-Head Comparison

While both AHR and WELL operate in the healthcare REIT space, the contrast in their positioning is stark. WELL is a mega-cap industry leader with an enterprise value dwarfing that of AHR by a factor of roughly ten times or more. This scale advantage translates into superior access to capital markets, A-grade credit ratings, and the capacity to execute multi-billion-dollar portfolio transactions — such as the Barchester and HC-One UK acquisitions — that are simply not available to smaller competitors.

On the growth front, however, AHR has demonstrated that smaller size can translate into higher percentage SSNOI gains. The company's SHOP segment posted 25.2% SSNOI growth in 2025, exceeding WELL's already impressive SHO SSNOI growth of approximately 20.4% in the fourth quarter. AHR's total portfolio SSNOI growth of 14.2% for 2025 was roughly in line with WELL's 15% total portfolio growth in the fourth quarter. The difference lies in base effects and diversification: WELL is pouring massive capital into a strategic concentration in pure-play senior housing while exiting outpatient medical, whereas AHR maintains a more balanced multi-segment approach that includes integrated health campuses, outpatient medical, and triple-net leases alongside senior housing.

Risk profiles diverge meaningfully. WELL's balance sheet, with net debt-to-EBITDA near 3.0x and over $5 billion in cash, alongside its A-grade credit ratings, provides a substantial cushion against cyclical headwinds or interest rate volatility. AHR, while improving its leverage to 3.4x net debt-to-EBITDA, remains a smaller and younger public company with less financial firepower and a higher cost of capital. Its P/E (price-to-earnings) ratio has also expanded considerably, reflecting market enthusiasm but also elevated valuation risk. From a sentiment standpoint, both stocks have enjoyed strong institutional interest, but WELL's massive scale and index inclusion afford it deeper and stickier institutional ownership. For income-oriented investors, both pay dividends — WELL at a quarterly rate of $0.74 per share and AHR at $0.25 per share quarterly — with WELL offering a longer track record of consecutive payouts, now exceeding 218 quarters.

Tickeron AI Verdict

Based on observable trend data, relative positioning, and current market dynamics, Tickeron's AI-driven analytical framework would likely lean in favor of Welltower (WELL) for investors prioritizing stability, balance-sheet strength, and institutional-grade exposure to the senior housing megatrend. The combination of A-category credit ratings, enormous liquidity, a proven 13-quarter streak of above-20% SHO SSNOI growth, and a bold strategic repositioning toward pure-play senior housing creates a compelling mosaic of trend consistency and operational momentum. However, American Healthcare REIT (AHR) presents a potentially attractive alternative for those seeking higher percentage growth rates and a more diversified healthcare real estate exposure, albeit with greater execution risk and a less-established public-market track record. The AI's probabilistic assessment would recognize that both stocks benefit from the same powerful demographic tailwinds, but WELL's superior scale, credit profile, and demonstrated ability to execute large-scale capital recycling give it a marginally higher probability of sustaining risk-adjusted outperformance in the current environment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations